Table 1.

Patient Demographics

Variables	Entire Cohort (n = 52)	Suspected COVID (n = 24)	Nonsuspected COVID (n = 28)	P Value
Age (Y)	52.3 ± 12.8	54.0 ± 10.2	50.6 ± 14.9	0.34
Female	15 (28.9)	9 (37.5)	6 (21.4)	0.20
Diabetes	10 (19.2)	2 (8.3)	8 (28.6)	0.086
Hypertension	32 (61.5)	18 (75.0)	14 (50.0)	0.065
Dyslipidemia	14 (26.9)	6 (25.0)	8 (28.6)	0.77
Renal function at arrival
eGFR*
≥ 90	31 (59.6)	13 (54.2)	18 (64.3)	0.46
60-89	10 (19.2)	6 (25.0)	4 (14.3)	0.33
30-59	7 (13.5)	3 (12.5)	4 (14.3)	1.00
15-29	3 (5.8)	1 (4.2)	2 (7.1)	1.00
< 15	1 (1.9)	1 (4.2)	0	0.46
Dialysis	1 (1.9)	1 (4.2)	0	0.49
COPD	2 (3.9)	2 (8.3)	0	1.00
Body mass index	27.4 ± 6.2	26.5 ± 4.6	28.3 ± 7.4	0.35
Current smoker	19 (36.5)	9 (37.5)	10 (35.7)	0.89
Left ventricular ejection fraction	58.2 ± 17.4	55.9 ± 23.5	60.6 ± 6.8	0.39
Aortic insufficiency ≥ moderate	11 (21.2)	5 (20.8)	6 (21.4)	1.00
Previous cardiovascular surgery	5 (9.6)	2 (8.3)	3 (10.7)	1.00
DeBakey Classification				0.77
Type I	47 (90.4)	22 (91.7)	25 (89.3)
Type II	5 (9.6)	2 (8.3)	3 (10.7)
Cardiac tamponade	2 (3.9)	0	2 (7.1)	0.49
End-organ malperfusion	20 (38.5)	7 (29.2)	13 (46.4)	0.20
Culprit organ
Mesenteric	4 (20.0)	1 (14.3)	3 (23.1)	1.00
Renal	2 (10.0)	1 (14.3)	1 (7.7)	1.00
Legs	7 (35.0)	4 (57.1)	3 (23.1)	0.17
Cerebral	3 (15.0)	1 (14.3)	2 (15.4)	1.00
Coronary	2 (10.0)	0	2 (15.4)	0.52
Spinal cord	1 (5.0)	0	1 (7.7)	1.00
Others	1 (5.0)	0	1 (7.7)	1.00

^⁎Estimated using the Cockcroft-Gault formula, male: ([140 − age] × weight in kg)/(serum creatinine × 72), female: multiplied by 0.85. COVID-19, coronavirus disease 2019; COPD, chronic obstructive lung disease; eGFR, estimated glomerular filtration rate.